A new blood test that could help doctors identify whether a patient has Alzheimer’s disease was cleared by the FDA last week.

The FDA has cleared Elecsys pTau181, the first blood test for use in primary care to help rule out Alzheimer’s disease in ...

This transcript has been edited for clarity. Hi. I’m Art Caplan. I'm at the Division of Medical Ethics at NYU Grossman School of Medicine in New York City. The FDA recently cleared, for the first time ...

The FDA has granted 510(k) clearance to a blood-based biomarker test indicated for early detection of Alzheimer’s disease and other causes of cognitive decline within a primary care setting, according ...

A Labcorp team member draws blood from a patient.Labcorp Labcorp, one of the country’s largest providers of diagnostic ...

One of the most frightening things about Alzheimer's disease is how difficult it is to diagnose early. Now, University of ...

Diagnosing Alzheimer’s disease has long relied on expensive and invasive procedures, often delaying care until symptoms are well advanced. With the recent US Food and Drug Administration (FDA) ...

La Jolla researchers say there is a pressing need for cost-effective tests for markers of Alzheimer’s disease and related dementia in groups considered underrepresented in studies — particularly ...

Researchers at Lund University in Sweden have developed a digital cognitive test for diagnosing Alzheimer's disease that is intended for use in primary care. "This digital test, which patients perform ...

Scientists have designed a new cognitive test that diagnoses patients more accurately with Alzheimer's. The digital test times how long it takes patients to remember objects and make word associations ...

The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...